Physician profile
Mark Joseph
NPI 1710106067
$43,915.79
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,345 · 2020: $7,107 · 2021: $18K · 2022: $4,672 · 2023: $5,139 · 2024: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,859 · Food and Beverage: $1,037 · Travel and Lodging: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,858.73 |
| Food and Beverage | $1,036.90 |
| Travel and Lodging | $771.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $28,696.83 | 2019-2024 | Angiovac, Alphavac |
| Medtronic Vascular, INC. | $4,654.04 | 2019 | |
| Neptune Medical INC. | $3,858.73 | 2023 | |
| Boston Scientific Corporation | $2,847.12 | 2022-2023 | |
| Ancora Heart, INC. | $1,489.68 | 2019-2024 | Accucinch |
| Medtronic, INC. | $1,252.37 | 2021-2023 | Apollotm |
| Abbott Laboratories | $354.34 | 2020-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $273.70 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Ethicon US, LLC | $139.31 | 2024 | Echelon Flex, Echelon Endopath, Evarrest |
| Avanos Medical | $116.73 | 2019 | |
| Abiomed | $112.21 | 2023 | Impella |
| Bolton Medical INC | $106.70 | 2023 | Treo Abdominal Stent-Graft System |
| Livanova USA, INC. | $14.03 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.